Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5- and 10-year survivors

  • Chua T
  • Saxena A
  • Chu F
 et al. 
  • 21


    Mendeley users who have this article in their library.
  • 26


    Citations of this article.


Hepatic resection of colorectal liver metastases (CLM) is now regarded the standard of care. Evaluation of true long-term survivors will demonstrate the curative potential of this therapy with cure being defined as actual 10-year survival versus a satisfactory oncological outcome of 5-year survival. Limited data exists on outcomes of patients beyond 5 years. Studying the rates of cure and predictive factors for cure are essential to define the true benefit of this therapy.

Author-supplied keywords

  • colorectal cancer
  • cure
  • hepatectomy
  • liver metastasis
  • long-term survival

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free